Table 6.
Prediction of patient outcomes by FST in patients with elevated biomarker levels
| Variable | Urine NGAL>150 ng/ml (n=44) | Urine TIMP-2×IGFBP-7>0.3 (n=32) | ||||
|---|---|---|---|---|---|---|
| Patients, n (%) | AUC±SEM | P Value | Patients, n | AUC±SEM | P Value | |
| Progression to AKIN stage 3 | 19 (43.2) | 0.86±(0.06 | <0.001 | 11 (34.4) | 0.90±0.06 | <0.001 |
| Receipt of inpatient RRT | 7 (15.9) | 0.91±0.06 | <0.001 | 4 (12.5) | 0.91±0.08 | 0.009 |
| Inpatient death | 12 (27.3) | 0.72±(0.10 | 0.03 | 5 (15.6) | 0.53±0.19 | 0.85 |
| Progression to AKIN stage 3 or inpatient death | 24 (54.5) | 0.89±0.06 | <0.001 | 14 (43.8) | 0.81±0.10 | 0.003 |